PIII — P3 Health Partners Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapValue Trap

Annual income statement for P3 Health Partners, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	146	486	637	1,049	1,266
Cost of Revenue
Gross Profit	4.45	0.028	-22	-7.75	31.6
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	185	521	825	2,610	1,434
Operating Profit	-39.5	-35.1	-188	-1,561	-168
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-42.9	-45.4	-204	-1,560	-184
Provision for Income Taxes
Net Income After Taxes	-42.9	-45.4	-204	-1,562	-186
Minority Interest
Net Income Before Extraordinary Items
Net Income	-35	-41.1	-156	-270	-57.8
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-35	-41.1	-156	-270	-57.8
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.842	-0.988	-3.76	14.3	-0.59